Skip to content
JoelGalvan

JoelGalvan

View Video Stories
  • Home
  • Business
  • Culture
  • Sports
  • Home
  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.
  • Home
  • Colitis

Tag: Colitis

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
Posted in Business

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

Estimated read time 14 min read
Posted on February 22, 2025
by Joelgalvan

This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…

Learn More Leave a Comment on Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

Recent Posts

  • Former Miami guard Hanna Cavinder reacts as sister Haley poses in chic summer outfit
  • Jamie Gittens transfer: Chelsea make offer for Borussia Dortmund star ahead of Club World Cup deadline | Football News
  • Why Australia cannot ignore the young talent coming through with a World Cup on the horizon
  • Former rivals Baker Tilly and Moss Adams just merged as private equity reshapes accounting. Their CEOs explain why they did the deal.
  • Vic Fangio Says He Feels ‘Good’ About Eagles’ Defense This Year

Recent Comments

No comments to show.

Archives

  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Categories

  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.